These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18580624)

  • 1. Severe rhabdomyolysis associated with raltegravir use.
    Zembower TR; Gerzenshtein L; Coleman K; Palella FJ
    AIDS; 2008 Jul; 22(11):1382-4. PubMed ID: 18580624
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature.
    Croce F; Vitello P; Dalla Pria A; Riva A; Galli M; Antinori S
    Int J STD AIDS; 2010 Nov; 21(11):783-5. PubMed ID: 21187364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of rhabdomiolysis associated with raltegravir use.
    Dori L; Buonomini AR; Viscione M; Sarmati L; Andreoni M
    AIDS; 2010 Jan; 24(3):473-5. PubMed ID: 20087078
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbation of depression associated with starting raltegravir: a report of four cases.
    Harris M; Larsen G; Montaner JS
    AIDS; 2008 Sep; 22(14):1890-2. PubMed ID: 18753871
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review.
    Gray J; Young B
    AIDS Patient Care STDS; 2009 Sep; 23(9):689-90. PubMed ID: 19663717
    [No Abstract]   [Full Text] [Related]  

  • 6. Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
    Cabrera C
    Curr Opin Investig Drugs; 2008 Aug; 9(8):885-98. PubMed ID: 18666037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrase inhibitor: raltegravir also as first line therapy].
    MMW Fortschr Med; 2010 Apr; 152(17):48. PubMed ID: 20509261
    [No Abstract]   [Full Text] [Related]  

  • 8. Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
    Buzón MJ; Marfil S; Puertas MC; Garcia E; Clotet B; Ruiz L; Blanco J; Martinez-Picado J; Cabrera C
    Antivir Ther; 2008; 13(7):881-93. PubMed ID: 19043922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raltegravir, a new HIV integrase inhibitor.
    Gandhi RT
    AIDS Clin Care; 2007 Dec; 19(12):105. PubMed ID: 18399003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA notifications. Raltegravir indication extended for treatment-naive patients.
    AIDS Alert; 2009 Aug; 24(8):93. PubMed ID: 19705587
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative use of raltegravir-containing regimen as induction therapy: very rapid decline of HIV-1 viral load.
    Papendorp SG; van den Berk GE
    AIDS; 2009 Mar; 23(6):739. PubMed ID: 19279447
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.
    TreatmentUpdate; 2007 Feb; 19(2):8-9. PubMed ID: 17447316
    [No Abstract]   [Full Text] [Related]  

  • 13. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics.
    Brainard DM; Friedman EJ; Jin B; Breidinger SA; Tillan MD; Wenning LA; Stone JA; Chodakewitz JA; Wagner JA; Iwamoto M
    J Clin Pharmacol; 2011 Mar; 51(3):422-7. PubMed ID: 20457591
    [No Abstract]   [Full Text] [Related]  

  • 15. [Integrase inhibition--a new mode of action in HIV therapy].
    van Lunzen J; Degen O
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():64-7. PubMed ID: 19031567
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raltegravir: initially as effective as standard therapy].
    Warpakowski A
    MMW Fortschr Med; 2010 Apr; 152(17):49. PubMed ID: 20509262
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HIV agents. Raltegravir--other issues.
    TreatmentUpdate; 2007 Feb; 19(2):9-10. PubMed ID: 17447317
    [No Abstract]   [Full Text] [Related]  

  • 18. DRESS syndrome associated with raltegravir.
    Zhang KS; Modi GM; Hsu S
    Dermatol Online J; 2011 Aug; 17(8):14. PubMed ID: 21906494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 20. Raltegravir: the first in a new class of integrase inhibitors for the treatment of HIV.
    Sayana S; Khanlou H
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):419-26. PubMed ID: 18662108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.